Published in Br J Ophthalmol on August 30, 2006
Change in prostaglandin expression levels and synthesizing activities in dry eye disease. Ophthalmology (2012) 2.07
Expression profile of inflammatory cytokines in aqueous from glaucomatous eyes. Mol Vis (2012) 1.26
Multiplex cytokine analysis reveals elevated concentration of interleukin-8 in glaucomatous aqueous humor. Invest Ophthalmol Vis Sci (2010) 1.12
Antibody protein array analysis of the tear film cytokines. Optom Vis Sci (2008) 1.00
The role of the cytokines in the pathogenesis of pseudoexfoliation syndrome. Int J Ophthalmol (2013) 0.98
Corneal graft rejection 10 years after penetrating keratoplasty in the cornea donor study. Cornea (2014) 0.94
Conjunctiva-associated lymphoid tissue (CALT) reactions to antiglaucoma prostaglandins with or without BAK-preservative in rabbit acute toxicity study. PLoS One (2012) 0.91
Changes to tear cytokines of type 2 diabetic patients with or without retinopathy. Mol Vis (2010) 0.90
Tear cytokine profile as a noninvasive biomarker of inflammation for ocular surface diseases: standard operating procedures. Invest Ophthalmol Vis Sci (2013) 0.87
In vitro and in vivo experimental studies on trabecular meshwork degeneration induced by benzalkonium chloride (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc (2012) 0.85
Effects of benzalkonium chloride on THP-1 differentiated macrophages in vitro. PLoS One (2013) 0.84
Benzalkonium chloride and glaucoma. J Ocul Pharmacol Ther (2013) 0.82
Complications of selective laser trabeculoplasty: a review. Clin Ophthalmol (2016) 0.79
Interferon-gamma (IFN-γ)-mediated retinal ganglion cell death in human tyrosinase T cell receptor transgenic mouse. PLoS One (2014) 0.77
Effect of latanoprost and timolol on the histopathology of the human conjunctiva. Br J Ophthalmol (2008) 0.77
Efficacy and patient tolerability of travoprost BAK-free solution in patients with open-angle glaucoma and ocular hypertension. Clin Ophthalmol (2010) 0.77
Cytokine changes in tears and relationship to contact lens discomfort. Mol Vis (2015) 0.76
Differential Protein Expression Profiles in Glaucomatous Trabecular Meshwork: An Evaluation Study on a Small Primary Open Angle Glaucoma Population. Adv Ther (2016) 0.76
Changes in Tear Cytokine Concentrations Following Discontinuation of Soft Contact Lenses-A Pilot Study. Eye Contact Lens (2016) 0.75
Cytokine biomarkers in tear film for primary open-angle glaucoma. Clin Ophthalmol (2017) 0.75
Multiplexed particle-based flow cytometric assays. J Immunol Methods (2000) 5.09
Multiplex bead array assays for detection of soluble cytokines: comparisons of sensitivity and quantitative values among kits from multiple manufacturers. Cytometry B Clin Cytom (2004) 3.52
Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca. Curr Eye Res (1999) 2.75
Validation and comparison of luminex multiplex cytokine analysis kits with ELISA: determinations of a panel of nine cytokines in clinical sample culture supernatants. J Reprod Immunol (2005) 2.70
Simultaneous measurement of six cytokines in a single sample of human tears using microparticle-based flow cytometry: allergics vs. non-allergics. J Immunol Methods (2001) 2.22
Effects of benzalkonium chloride on growth and survival of Chang conjunctival cells. Invest Ophthalmol Vis Sci (1999) 2.16
Corneal and conjunctival changes caused by commonly used glaucoma medications. Cornea (2004) 2.10
Adverse effects of topical antiglaucoma medication. I. The conjunctival cell profile. Arch Ophthalmol (1994) 1.80
Conjunctival proinflammatory and proapoptotic effects of latanoprost and preserved and unpreserved timolol: an ex vivo and in vitro study. Invest Ophthalmol Vis Sci (2004) 1.70
In vitro study of inflammatory potential and toxicity profile of latanoprost, travoprost, and bimatoprost in conjunctiva-derived epithelial cells. Invest Ophthalmol Vis Sci (2005) 1.63
Side effects of antiglaucomatous drugs on the ocular surface. Curr Opin Ophthalmol (1996) 1.52
Conjunctival epithelial cell expression of interleukins and inflammatory markers in glaucoma patients treated over the long term. Ophthalmology (2004) 1.46
The effect of preservatives and antiglaucomatous medication on the histopathology of the conjunctiva. Graefes Arch Clin Exp Ophthalmol (1994) 1.31
Comparison of the effects of preserved and unpreserved formulations of timolol on the ocular surface of albino rabbits. Ophthalmic Res (2000) 1.25
Adverse effects of topical antiglaucomatous medications on the conjunctiva. Br J Ophthalmol (1993) 1.23
Inflammatory cytokines in the tears of patients with ocular rosacea. Ophthalmology (1997) 1.17
CCR 4 and CCR 5 expression in conjunctival specimens as differential markers of T(H)1/ T(H)2 in ocular surface disorders. J Allergy Clin Immunol (2005) 1.09
Inflammatory cytokines in normal human tears. Curr Eye Res (1998) 1.06
A new microsphere-based immunofluorescence assay using flow cytometry. J Immunol Methods (1988) 1.03
Alteration pattern of tear cytokines during the course of a day: diurnal rhythm analyzed by multicytokine assay. Cytokine (2006) 0.94
Mechanisms of failure in glaucoma filtering surgery: a consequence of antiglaucomatous drugs? Int J Clin Pharmacol Res (1996) 0.87
Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication. Br J Ophthalmol (2002) 2.67
Effects of benzalkonium chloride on growth and survival of Chang conjunctival cells. Invest Ophthalmol Vis Sci (1999) 2.16
Ocular symptoms and signs with preserved and preservative-free glaucoma medications. Eur J Ophthalmol (2007) 2.04
Methanol poisoning: two case studies of blindness in Indonesia. Int Ophthalmol (2011) 1.96
Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes. Invest Ophthalmol Vis Sci (2000) 1.74
Avocado/soybean unsaponifiables, ASU EXPANSCIENCE, are strictly different from the nutraceutical products claiming ASU appellation. Osteoarthritis Cartilage (2008) 1.52
Conjunctival and corneal reactions in rabbits following short- and repeated exposure to preservative-free tafluprost, commercially available latanoprost and 0.02% benzalkonium chloride. Br J Ophthalmol (2008) 1.50
Hyperlordosis as a possible factor in the development of spinal cord infarction. Br J Anaesth (2003) 1.45
Toxicity of preserved and unpreserved antiglaucoma topical drugs in an in vitro model of conjunctival cells. Curr Eye Res (2000) 1.45
Emerging treatment paradigms of ocular surface disease: proceedings of the Ocular Surface Workshop. Br J Ophthalmol (2009) 1.40
Quaternary ammoniums and other preservatives' contribution in oxidative stress and apoptosis on Chang conjunctival cells. Invest Ophthalmol Vis Sci (2001) 1.39
Direct costs of glaucoma and severity of the disease: a multinational long term study of resource utilisation in Europe. Br J Ophthalmol (2005) 1.36
Differences in meibomian fatty acid composition in patients with meibomian gland dysfunction and aqueous-deficient dry eye. Br J Ophthalmol (2008) 1.32
Falsely elevated intraocular pressure due to increased central corneal thickness. Graefes Arch Clin Exp Ophthalmol (1999) 1.29
Comparison of the effects of preserved and unpreserved formulations of timolol on the ocular surface of albino rabbits. Ophthalmic Res (2000) 1.25
Comparison of the cytotoxic, pro-oxidant and pro-inflammatory characteristics of different oxysterols. Cell Biol Toxicol (2005) 1.21
Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A. Invest Ophthalmol Vis Sci (2001) 1.20
Types of choroidal neovascularisation in newly diagnosed exudative age-related macular degeneration. Br J Ophthalmol (2007) 1.16
Flow cytometric analysis of conjunctival epithelium in ocular rosacea and keratoconjunctivitis sicca. Ophthalmology (2000) 1.14
Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistance. Biochem Pharmacol (1992) 1.10
[Smartphones in ophthalmology]. J Fr Ophtalmol (2013) 1.09
Involvement of a calcium-dependent dephosphorylation of BAD associated with the localization of Trpc-1 within lipid rafts in 7-ketocholesterol-induced THP-1 cell apoptosis. Cell Death Differ (2004) 1.06
Comparative study on the cytotoxic effects of benzalkonium chloride on the Wong-Kilbourne derivative of Chang conjunctival and IOBA-NHC cell lines. Mol Vis (2008) 1.04
Side effects of oxysterols: cytotoxicity, oxidation, inflammation, and phospholipidosis. Braz J Med Biol Res (2008) 1.04
Mitochondrial activity and glutathione injury in apoptosis induced by unpreserved and preserved beta-blockers on Chang conjunctival cells. Invest Ophthalmol Vis Sci (2001) 1.03
Detection of JC virus DNA in the peripheral blood leukocytes of HIV-infected patients. AIDS (1996) 1.02
[Conjunctivitis and ocular parasitic diseases]. J Fr Ophtalmol (1999) 1.02
Effects of oxysterols on cell viability, inflammatory cytokines, VEGF, and reactive oxygen species production on human retinal cells: cytoprotective effects and prevention of VEGF secretion by resveratrol. Eur J Nutr (2010) 1.01
Expression of Fas-Fas ligand antigens and apoptotic marker APO2.7 by the human conjunctival epithelium. Positive correlation with class II HLA DR expression in inflammatory ocular surface disorders. Exp Eye Res (1998) 1.01
Histopathological effects of topical ophthalmic preservatives on rat corneoconjunctival surface. Curr Eye Res (1998) 1.01
Effects of aFGF and bFGF on wound healing in rabbit corneas. Curr Eye Res (1987) 0.98
Impairment of endothelium-dependent arterial relaxation by high-fat feeding in ApoE-deficient mice: toward normalization by human ApoA-I expression. Circulation (1999) 0.98
[Ocular surface investigations in dry eye]. J Fr Ophtalmol (2007) 0.98
Acidic FGF and other growth factors in preretinal membranes from patients with diabetic retinopathy and proliferative vitreoretinopathy. Ophthalmic Res (1991) 0.97
Changes in meibomian fatty acids and clinical signs in patients with meibomian gland dysfunction after minocycline treatment. Br J Ophthalmol (2008) 0.96
Plasma phospholipid transfer protein prevents vascular endothelium dysfunction by delivering alpha-tocopherol to endothelial cells. FASEB J (1999) 0.96
Proton MR spectroscopy in herpes simplex encephalitis: assessment of neuronal loss. J Comput Assist Tomogr (1990) 0.96
Acute postoperative endophthalmitis caused by Staphylococcus lugdunensis. J Clin Microbiol (2007) 0.95
Evaluation of keratic precipitates and corneal endothelium in Fuchs' heterochromic cyclitis by in vivo confocal microscopy. Br J Ophthalmol (2008) 0.95
Evaluation of corneal stromal changes in vivo after laser in situ keratomileusis with confocal microscopy. Ophthalmology (2001) 0.95
Suitability of and tolerance to Iotrolan 300 in bronchography via the fibreoptic bronchoscope. Thorax (1990) 0.95
Distinct Chk2 activation pathways are triggered by genistein and DNA-damaging agents in human melanoma cells. J Biol Chem (2000) 0.94
Evolving European guidance on the medical management of neovascular age related macular degeneration. Br J Ophthalmol (2006) 0.93
Different patterns of IL-1beta secretion, adhesion molecule expression and apoptosis induction in human endothelial cells treated with 7alpha-, 7beta-hydroxycholesterol, or 7-ketocholesterol. FEBS Lett (1998) 0.92
Expression of CD40 and CD40 ligand in the human conjunctival epithelium. Invest Ophthalmol Vis Sci (2000) 0.92
Mitochondria-targeting drugs arsenic trioxide and lonidamine bypass the resistance of TPA-differentiated leukemic cells to apoptosis. Blood (2001) 0.92
[Pilot study of a new matrix therapy agent (RGTA OTR4120) in treatment-resistant corneal ulcers and corneal dystrophy]. J Fr Ophtalmol (2008) 0.92
Human melanoma cell lines differ in their capacity to release ADP and aggregate platelets. Br J Haematol (1994) 0.92
[In vivo confocal microscopy and ocular surface diseases: anatomical-clinical correlations]. J Fr Ophtalmol (2005) 0.91
Efficacy of 0.18% hypotonic sodium hyaluronate ophthalmic solution in the treatment of signs and symptoms of dry eye disease. J Fr Ophtalmol (2012) 0.91
[Severe bilateral capsulorhexis contraction after cataract surgery in myotonic dystrophy: a case report]. J Fr Ophtalmol (2004) 0.91
The triple classification of dry eye for practical clinical use. Eur J Ophthalmol (2005) 0.90
Branched-chain fatty acids, increased in tears of blepharitis patients, are not toxic for conjunctival cells. Br J Ophthalmol (2009) 0.90
Reduction of quaternary ammonium-induced ocular surface toxicity by emulsions: an in vivo study in rabbits. Mol Vis (2008) 0.90
Ceramide generation occurring during 7beta-hydroxycholesterol- and 7-ketocholesterol-induced apoptosis is caspase independent and is not required to trigger cell death. Cell Death Differ (2001) 0.90
[Ocular proprioception and developmental dyslexia. Sixty clinical observations]. J Fr Ophtalmol (2005) 0.90
[Contribution of in vivo confocal microscopy to limbal tumor evaluation]. J Fr Ophtalmol (2005) 0.90
An improved assay for the detection of Toxoplasma gondii antibodies in human serum by flow cytometry. Cytometry (1993) 0.90
[Utility of the Visante OCT in the follow-up of glaucoma surgery]. J Fr Ophtalmol (2007) 0.90
Evidence of oxidative stress in very long chain fatty acid--treated oligodendrocytes and potentialization of ROS production using RNA interference-directed knockdown of ABCD1 and ACOX1 peroxisomal proteins. Neuroscience (2012) 0.90
Comparison of morphological and functional characteristics of primary-cultured human conjunctival epithelium and of Wong-Kilbourne derivative of Chang conjunctival cell line. Exp Eye Res (2004) 0.89
Apoptosis without decrease of cell DNA content. FEBS Lett (1995) 0.89
[Consensus on neovascular glaucoma]. J Fr Ophtalmol (2000) 0.88
Inhibitors of arterial relaxation among components of human oxidized low-density lipoproteins. Cholesterol derivatives oxidized in position 7 are potent inhibitors of endothelium-dependent relaxation. Circulation (1997) 0.88
[Corneal sensitivity in patients treated medically for glaucoma or ocular hypertension]. J Fr Ophtalmol (2011) 0.88
Immobilized thylakoids in a cross-linked albumin matrix: effects of cations studied by electron microscopy, fluorescence emission, photoacoustic spectroscopy, and kinetic measurements. Plant Physiol (1982) 0.88
Ocular surface changes induced by contact lens wear. Cornea (2001) 0.87
Two human melanoma cell-line variants with enhanced in vivo tumor growth and metastatic capacity do not express the beta 3 integrin subunit. Eur J Biochem (1994) 0.87
[Contribution of in vivo confocal microscopy to diagnosis of invasive ocular surface squamous neoplasia: a case report]. J Fr Ophtalmol (2010) 0.86
Interferon-gamma induces apoptosis and expression of inflammation-related proteins in Chang conjunctival cells. Invest Ophthalmol Vis Sci (1999) 0.86
Consequences of chondrocyte hypertrophy on osteoarthritic cartilage: potential effect on angiogenesis. Osteoarthritis Cartilage (2013) 0.86
Confocal microscopic examination of trabecular meshwork removed during ab externo trabeculectomy. Br J Ophthalmol (2002) 0.85
Multiple endpoint analysis of BAC-preserved and unpreserved antiallergic eye drops on a 3D-reconstituted corneal epithelial model. Mol Vis (2011) 0.85
[Advantages of the in vivo HRT2 corneal confocal microscope for investigation of the ocular surface epithelia]. J Fr Ophtalmol (2004) 0.85
[Clinical tolerance of antiglaucoma eyedrops with and without a preservative. Results of an unpublished survey in Europe]. J Fr Ophtalmol (1999) 0.85
[Preservatives in eye drops: toward awareness of their toxicity]. J Fr Ophtalmol (2010) 0.84
CA 19-9 ELISA test: a new method for studying mucus changes in tears. Br J Ophthalmol (1998) 0.84
[The influence of ocular surface diseases in the management of glaucoma]. J Fr Ophtalmol (2011) 0.84
[Study and prevention of contact lens-related microbial keratitis with a standardized questionnaire]. J Fr Ophtalmol (2010) 0.83
Fas- and interferon gamma-induced apoptosis in Chang conjunctival cells: further investigations. Invest Ophthalmol Vis Sci (2000) 0.83
Immunohistochemical analysis of vascular endothelial growth factor (VEGF) and p53 expression in pterygium from Tunisian patients. Pathol Biol (Paris) (2009) 0.83
[Screening diabetic retinopathy in Burgundy with an itinerant nonmydriatic camera]. J Fr Ophtalmol (2007) 0.83
Pattern-recognition receptors in pulp defense. Adv Dent Res (2011) 0.83
[Architectural analysis of clear corneal incisions using Visante OCT in acute postoperative endophthalmitis]. J Fr Ophtalmol (2010) 0.83
Cytoprotective effect against UV-induced DNA damage and oxidative stress: role of new biological UV filter. Eur J Pharm Sci (2006) 0.82
Apoptosis induced by polyclonal antilymphocyte globulins in human B-cell lines. Blood (1994) 0.82
Inhibition by cholesterol oxides of NO release from human vascular endothelial cells. Arterioscler Thromb Vasc Biol (1998) 0.82
Trefoil factor family 1, MUC5AC and human leucocyte antigen-DR expression by conjunctival cells in patients with glaucoma treated with chronic drugs: could these markers predict the success of glaucoma surgery? Br J Ophthalmol (2006) 0.82
Macular folds after retinal detachment surgery: the possible impact of outpatient surgery. Graefes Arch Clin Exp Ophthalmol (2011) 0.82
Analytical methods for evaluation on whole cells of human papillomavirus infection. Bull Cancer (1995) 0.82
[Analogies between atherosclerosis and age-related maculopathy: expected roles of oxysterols]. J Fr Ophtalmol (2006) 0.82